ConductScience.org, home

Paper9686352

Neurodevelopmental outcome of long-term therapy of urea cycle disorders in Japan.

Uchino T and 2 others. J Inherit Metab Dis, 1998. Cited by 115 papers, by iCite.

Cite this record

ConductScience Library. Neurodevelopmental outcome of long-term therapy of urea cycle disorders in Japan. Papers, record 9686352. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9686352

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Neurodevelopmental outcome of long-term therapy of urea cycle disorders in Japan.
PubMed
Journal
J Inherit Metab Dis
PubMed
Year
1998
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
115
iCite
Relative citation ratio, by iCite
4.16
iCite
Revised in PubMed
2026-10-16
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Uchino TT
2Endo FF
3Matsuda II

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Amino Acid Metabolism, Inborn ErrorsMajor topic
Neurobehavioral ManifestationsMajor topic
Ornithine Carbamoyltransferase Deficiency DiseaseMajor topic
UreaMajor topic
Age of Onset
Ammonia
Female
Humans
Hyperargininemia
Infant
Infant, Newborn
Intelligence
Japan
Male
Retrospective Studies
Survival Rate
Treatment Outcome

Source PubMed

Download CSV of topics

References9

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16717540Neurologic outcome in children with inborn errors of urea synthesis. Outcome of urea-cycle enzymopathies.N Engl J Med1984https://conductscience.org/library/papers/6717540PubMed
22012137Retrospective survey of urea cycle disorders: Part 1. Clinical and laboratory observations of thirty-two Japanese male patients with ornithine transcarbamylase deficiency.Am J Med Genet1991https://conductscience.org/library/papers/2012137PubMed
39286441The ornithine transcarbamylase (OTC) gene: mutations in 50 Japanese families with OTC deficiency.Am J Med Genet1997https://conductscience.org/library/papers/9286441PubMed
41746614Retrospective survey of urea cycle disorders: Part 2. Neurological outcome in forty-nine Japanese patients with urea cycle enzymopathies.Am J Med Genet1991https://conductscience.org/library/papers/1746614PubMed
57649538Molecular basis of phenotypic variation in patients with argininemia.Hum Genet1995https://conductscience.org/library/papers/7649538PubMed
68486760Carbamyl phosphate synthetase I deficiency. One base substitution in an exon of the CPS I gene causes a 9-basepair deletion due to aberrant splicing.J Clin Invest1993https://conductscience.org/library/papers/8486760PubMed
72063931Estimated frequency of urea cycle enzymopathies in Japan.Am J Med Genet1991https://conductscience.org/library/papers/2063931PubMed
87981719Identification of mutations (D128G, H141L) in the liver arginase gene of patients with hyperargininemia.Hum Mutat1994https://conductscience.org/library/papers/7981719PubMed
98778603Long-term treatment of girls with ornithine transcarbamylase deficiency.N Engl J Med1996https://conductscience.org/library/papers/8778603PubMed

Download CSV of references

Cited by55

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 115 citations.

PMIDTitleJournalYearIn PapersSource
42306244Long-Term Efficacy and Safety of Glycerol Phenylbutyrate in Japanese Patients With Urea Cycle Disorders: Results From a Phase 3 Switch-Over and 12-Month Extension Study.JIMD Rep2026https://conductscience.org/library/papers/42306244PubMed
38837457Quo vadis ureagenesis disorders? A journey from 90 years ago into the future.J Inherit Metab Dis2024https://conductscience.org/library/papers/38837457PubMed
36643675Factors associated with short-term survival in neonates with hyperammonemia.Transl Pediatr2022https://conductscience.org/library/papers/36643675PubMed
36620387Benefits of tailored disease management in improving tremor, white matter hyperintensities, and liver enzymes in a child with heterozygous X-linked ornithine transcarbamylase deficiency.Mol Genet Metab Rep2022https://conductscience.org/library/papers/36620387PubMed
36340787Novel pathogenic variant (c.2947C > T) of the carbamoyl phosphate synthetase 1 gene in neonatal-onset deficiency.Front Neurosci2022https://conductscience.org/library/papers/36340787PubMed
34805036Continuous Renal Replacement Therapy for Two Neonates With Hyperammonemia.Front Pediatr2021https://conductscience.org/library/papers/34805036PubMed
34665389Hyperammonemia in Inherited Metabolic Diseases.Cell Mol Neurobiol2022https://conductscience.org/library/papers/34665389PubMed
34646736Current status of surviving patients with arginase 1 deficiency in Japan.Mol Genet Metab Rep2021https://conductscience.org/library/papers/34646736PubMed
34357956Towards an Algorithm-Based Tailored Treatment of Acute Neonatal Hyperammonemia.Toxins (Basel)2021https://conductscience.org/library/papers/34357956PubMed
33995244Review of Multi-Modal Imaging in Urea Cycle Disorders: The Old, the New, the Borrowed, and the Blue.Front Neurol2021https://conductscience.org/library/papers/33995244PubMed
33317798CPS1: Looking at an ancient enzyme in a modern light.Mol Genet Metab2020https://conductscience.org/library/papers/33317798PubMed
33288448Severity-adjusted evaluation of newborn screening on the metabolic disease course in individuals with cytosolic urea cycle disorders.Mol Genet Metab2020https://conductscience.org/library/papers/33288448PubMed
33193012Novel Homozygous Missense Mutation in the ARG1 Gene in a Large Sudanese Family.Front Neurol2020https://conductscience.org/library/papers/33193012PubMed
33124615Considering Proximal Urea Cycle Disorders in Expanded Newborn Screening.Int J Neonatal Screen2020https://conductscience.org/library/papers/33124615PubMed
31268178Neuropsychological attributes of urea cycle disorders: A systematic review of the literature.J Inherit Metab Dis2019https://conductscience.org/library/papers/31268178PubMed
31110235Urea cycle disorders-update.J Hum Genet2019https://conductscience.org/library/papers/31110235PubMed
30961665High blood pressure, a red flag for the neonatal manifestation of urea cycle disorders.Orphanet J Rare Dis2019https://conductscience.org/library/papers/30961665PubMed
30671983
Impairment of cognitive function in ornithine transcarbamylase deficiency is global rather than domain-specific and is associated with disease onset, sex, maximum ammonium, and number of hyperammonemic events.
J Inherit Metab Dis2019https://conductscience.org/library/papers/30671983PubMed
29948653Early liver transplantation in neonatal-onset and moderate urea cycle disorders may lead to normal neurodevelopment.Metab Brain Dis2018https://conductscience.org/library/papers/29948653PubMed
29773863Low prevalence of argininosuccinate lyase deficiency among inherited urea cycle disorders in Korea.J Hum Genet2018https://conductscience.org/library/papers/29773863PubMed

See all 55 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9686352

GET https://conductscience.org/api/papers/v1/9686352/cited_by?page=2